Annual report pursuant to Section 13 and 15(d)

Basis of Presentation and Significant Accounting Policies - Schedule of Revenue Activities (Details)

v3.19.1
Basis of Presentation and Significant Accounting Policies - Schedule of Revenue Activities (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Total revenue $ 507,150 $ 12,503,599 $ 15,015,646 $ 12,683,226 $ 14,002,066 $ 7,369,376 $ 3,092,722 $ 40,709,621 [1],[2] $ 24,464,164 [1],[2]
Well Stimulation [Member]                    
Total revenue                 $ 40,709,621 $ 24,464,164
[1] The Argentina segment has been reclassified into discontinued operations.
[2] U.S. activity began in February 2017 with start-up expenses being incurred. The Company began recognizing U.S. revenue in late May 2017. Intersegment transactions included in revenues were not significant for any of the periods presented.